Posttraumatic Stress Disorder Clinical Trial
— CPT-TEXTOfficial title:
Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for Asynchronous Texting Based Trauma Focused Therapy for PTSD
There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital mental health interventions is low. This study will compare a texting-based EBT for PTSD to culturally-informed texting-based treatment for PTSD as usual, and it will also compare a unique incentive strategy to typical platform reminders aimed to prevent early discontinuation in therapy. This online study is open to individuals who live in 13 different states.
Status | Recruiting |
Enrollment | 400 |
Est. completion date | September 29, 2025 |
Est. primary completion date | June 1, 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: - Over the age of 18 residing in the United States - Criterion A event measured by the Life Events Checklist for DSM-5 (LEC-5) - Significant symptoms of PTSD as evidenced by a score of 33 or above on the PCL-5 - PTSD symptoms that began or increased during the COVID pandemic (per self-report) - Registered/registering on Talkspace for messaging-based therapy - Ownership of a personal device for texting - Residence in a state with therapist capacity on the Talkspace platform Exclusion Criteria: - Acute risk for suicidal thoughts and/or behaviors measured by the Columbia Suicide Severity Rating Scale Lifetime-Recent Screen - Psychosis or substance abuse that requires prioritization of treatment and/or higher level of care |
Country | Name | City | State |
---|---|---|---|
United States | Talkspace LLC | New York | New York |
United States | Stanford University | Palo Alto | California |
United States | University of Texas Health Sciences Center at San Antonio | San Antonio | Texas |
Lead Sponsor | Collaborator |
---|---|
Stanford University | National Institute of Mental Health (NIMH), Talkspace, The University of Texas Health Science Center at San Antonio, University of Pennsylvania |
United States,
Arango C, Wykes T, Moreno C. Mental health care and COVID-19. Lancet Psychiatry. 2020 Dec;7(12):1013. doi: 10.1016/S2215-0366(20)30480-6. No abstract available. — View Citation
Czeisler ME, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam SMW. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1. — View Citation
Hull TD, Malgaroli M, Connolly PS, Feuerstein S, Simon NM. Two-way messaging therapy for depression and anxiety: longitudinal response trajectories. BMC Psychiatry. 2020 Jun 12;20(1):297. doi: 10.1186/s12888-020-02721-x. — View Citation
Kaseda ET, Levine AJ. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020 Oct-Nov;34(7-8):1498-1514. doi: 10.1080/13854046.2020.1811894. Epub 2020 Aug 26. — View Citation
Malgaroli M, Hull TD, Wiltsey Stirman S, Resick P. Message Delivery for the Treatment of Posttraumatic Stress Disorder: Longitudinal Observational Study of Symptom Trajectories. J Med Internet Res. 2020 Apr 29;22(4):e15587. doi: 10.2196/15587. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PTSD Checklist for DSM-5 (PCL-5) | The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that evaluates the degree to which individuals have been bothered by PTSD symptoms tied to their most currently distressing event [114] . The monthly version will be administered at baseline and the weekly version thereafter. | Baseline through 24 weeks | |
Secondary | Patient Health Questionnaire (PHQ-9) | The PHQ-9 [115,116] is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders that will be administered on the schedule outlined in the table. The PHQ-9 is the 9-item depression module and is a multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression. | Baseline through 24 weeks | |
Secondary | The Brief Inventory of Psychosocial Functioning (B-IPF) | The Brief Inventory of Psychosocial Functioning (B-IPF; [117] ) is a 7-item self-report instrument measuring respondents' level of functioning over the past 30 days in seven life domains including: romantic, family, parenting, friendship, work, education, and self-care. | Baseline through 24 weeks | |
Secondary | The Client Satisfaction Questionnaire (CSQ) | The Client Satisfaction Questionnaire (CSQ; [118] ) is an 8-item measure of participant satisfaction with treatment. | Baseline through 24 weeks | |
Secondary | Working Alliance Inventory, Short Form (WAI-SF) | The Working Alliance Inventory, Short Form (WAI-SF, [125] ) is a measure to index the degree of therapeutic cohesion between the client and the therapist. | Week 1 through Week 12 | |
Secondary | Behavioral Intention | Behavioral Intention (BI; which captures motivation to engage in a behavior) will be measured to examine patterns of motivation in our treatment conditions and to investigate BI as the hypothesized mechanism of change in engagement. BI measures are created based on recommendations for constructing a very brief BI measure, a frequent approach to measuring this construct, which has demonstrated reliability [119-123] . Participants will be asked, "How likely or unlikely are you to complete (baseline) or continue (mid-treatment) treatment?" on a 7-item Likert scale ranging from "Extremely Unlikely" to "Extremely Likely" at the baseline and both mid-treatment assessments. | Baseline through week 8 | |
Secondary | Oppression-based traumatic stress inventory | An assessment of trauma-related symptoms related to oppression or race/ethnicity-based trauma. | Baseline through 24 weeks at 3 timepoints | |
Secondary | Post-traumatic Cognitions Inventory | Assessment of common beliefs after trauma | baseline through 24 weeks, at 3 timepoints | |
Secondary | Self-Report Altruism Scale (SRA) | Assessment of altruism via self-report | Baseline | |
Secondary | Cultural Humility Scale (CHS) | Assessment of important and central aspects of one's identity Assessment of customer perceptions of staff's cultural humility | Week 1 through week 13, at 4 timepoints | |
Secondary | Cultural Missed Opportunities (CMO) | Assessment of degree to which clients perceived that their therapist missed opportunities to discuss their cultural identity. | Week 1 through week 13, at 4 timepoints |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03384706 -
A Comparison of CPT Versus ART Versus WL
|
N/A | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03129204 -
Sensation Awareness Focused Training for Spouses
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT05113277 -
Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention
|
N/A | |
Recruiting |
NCT05327504 -
Written Exposure Therapy for Veterans With SUD and PTSD
|
N/A | |
Recruiting |
NCT05843695 -
Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety
|
N/A | |
Active, not recruiting |
NCT05530642 -
An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel
|
N/A | |
Completed |
NCT00644423 -
Omega-3 Fatty Acids and Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT02989987 -
NET for SGBV Survivors in Eastern DR Congo
|
N/A | |
Completed |
NCT02320799 -
Randomized Controlled Trial of Interpersonal Psychotherapy for Depression and PTSD Among HIV+ Women in Kenya
|
N/A | |
Recruiting |
NCT02293291 -
Thermal Clinic Treatment in Gulf War Illness
|
Phase 1/Phase 2 | |
Completed |
NCT02242136 -
Treatment of Posttraumatic Stress Disorder and Aggressive Behavior in Soldiers and Ex-combatants
|
N/A | |
Completed |
NCT02720497 -
The Efficacy of 90-Minute Versus 60-Minute Sessions of Prolonged Exposure for PTSD
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A | |
Completed |
NCT01693978 -
Contingency Outcomes in Prolonged Exposure
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01469754 -
Longitudinal Survey Analysis in Lymphoma Survivors
|
N/A | |
Terminated |
NCT01239173 -
Emotional Memory Reactivation in Posttraumatic Stress Disorder
|
Phase 3 | |
Completed |
NCT02362477 -
Telemental Health and Cognitive Processing Therapy for Female Veterans With Military-related PTSD
|
Phase 3 |